baber/WOPTO huggingface dataset:
Patent NZ-591256-A (NZ)
Title: Measuring sounds during expiration and inspiration and signalling if a ratio of the two exceeds a value
Inventor: ALDER MATTHEW
IPC: A61B5/08
Filed: 2007-01-04
Abstract: A method of detecting the occurrence of snoring by a patient is disclosed. The method comprises the steps of: (i) measuring a noise level with a sensor during an inspiration phase of the patient's breathing cycle; (ii) measuring a noise level with a sensor during an expiration phase of the patient's breathing cycle; (iii) using a processor to calculate a snore value as a function of the difference in the noise levels measured during the inspiration phase and the expiration phase; (iv) determining that snoring has occurred when the snore value is above a predetermined threshold; and (v) generating a snore signal to indicate that snoring has been detected.
Patent NZ-593319-A (NZ)
Title: A tiltable stand for an annular fan assembly
Inventor: GAMMACK PETER
IPC: F04D25/08
Filed: 2010-02-18
Abstract: A stand, for a fan assembly 10, comprising a base 40 and a body 42 tiltable relative to the base, the base 40 and body 42 each having an outer surface shaped so that adjoining portions thereof are substantially flush when the body 42 is in an untilted position. The stand may support an air outlet 14 of the fan assembly 10. The base 40 and body 42 may be substantially cylindrical and have interlocking means for retaining the body 42 on the base 40. Biasing means may be provided to urge the interlocking means together to resist movement of the body 42 from a tilted position. The air outlet 14 may comprise a nozzle having a mouth for emitting an airflow, the nozzle extending about an opening through which air from outside the nozzle is drawn by the airflow emitted from the mouth.
Patent NZ-594798-A (NZ)
Title: Method and system for distributing and enforcing policies applicable to device communications over a wireless access network
Inventor: RALEIGH GREGORY G
IPC: H04W4/50
Filed: 2010-01-28
Abstract: A process for distributing and enforcing policies applicable to device communications over a wireless access network and a network system are disclosed. The network system comprises a network element element corresponding to a network element destination and a service controller. The network element is configured to detect a device associated with a service processor with the device communicatively coupled to the network system over a wireless access network, and enforce a network element policy for monitored traffic from the device. The service controller is configured to provide a device service processor policy to the service processor with the device service processor policy having a device service processor service usage activity classification and having the network element destination for service usage activities determined to be included in the device service processor service usage activity classification. The device service processor policy is configured to assist the service processor in detecting a service activity. The service controller is further configured to identifying the service activity as being included in the device service processor service usage activity classification, and directing or routing traffic associated with the service activity over the wireless access network based on the network element destination, and provide, to the network element, the network element policy for monitored traffic from the device, the network element policy having a service usage charging policy, and a service usage control policy.
Patent NZ-598193-A (NZ)
Title: Chemically Modified Factor IX
Inventor: TURECEK PETER
IPC: A61K47/48
Filed: 2008-12-19
Abstract: Disclosed is a blood coagulation factor IX (FIX) with a FIX activation peptide region (AP region), wherein said AP region comprises a covalently coupled water-soluble hydrophilic polymer absent from biologically produced FIX, said covalently coupled water-soluble hydrophilic polymer being hydroxyethyl starch (HES) attached to said FIX via Asn-157 and/or Asn-167 of said FIX.
Patent NZ-601055-A (NZ)
Title: Radioimmunoconjugates and uses thereof
Inventor: LARSEN ROY H
IPC: A61K51/10
Filed: 2011-01-28
Abstract: 601055 Disclosed is a radioimmunoconjugate that binds human CD37 comprising: Murine monoclonal antibody HH1; A chelating linker; and A radionuclide selected from the group consisting of 177Lu, 212Pb, 225AC, 227TH and 90Y.
Patent NZ-616325-A (NZ)
Title: Saddle with adjustable blocks
Inventor: RONALD GORDON BATES
IPC: B68C1/04
Filed: 2013-10-04
Abstract: 615325 Disclosed is an equestrian saddle with adjustable leg blocks to provide an equestrian rider improved support and comfort when the saddle is set up for a riding configuration or a jumping configuration. The saddle has two flaps, and a block mounted to each flap for engagement by the leg of the rider, the block is mounted to the flap by a mounting system which permits the position of the block on the flap to be adjusted and which retains the block in its selected position on the flap by a clamping action between the block and the flap. The mounting system for each block on its respective flap comprises threaded fasteners extending from a base of the block through respective apertures in the flap, the apertures being enlarged in relation to a shank diameter of the threaded fasteners or screws to permit the adjustment of the block by movement of the fasteners within the apertures. The base of the block includes a substantially rigid plate and the screws extend through a substantially rigid plate at the inner side of the flap into the plate in the base of the block whereby tightening of the screws causes the flap to be clamped between the two plates. The apertures are shaped to permit the block to be adjusted relative to the flap between a forward position, a rear position and intermediate positions there between. The size of each aperture is such that in all possible adjusted positions of the block the apertures are concealed beneath the base of the block.
Patent NZ-623144-A (NZ)
Title: Tile levelling device
Inventor: PSAILA ANTHONY
IPC: E04F21/20
Filed: 2012-09-05
Abstract: A tile levelling and spacing device (12) which spaces a side of a first tile of a pair of adjacent tiles away from a side of a second tile of the pair of tiles. The tile levelling and spacing device has a base plate (20) having an upper surface (29) and a base surface; a central hub (22) which includes a stem aperture, each centrally located in the base plate (20), the stem aperture including internal threading; and at least one spacer body (24) which extend outwardly from the upper surface (20) of the base plate (20), wherein the at least one spacer body (24) includes: at least one first engagement portion (25) which is configured to abut against a side of a first tile of the pair of adjacent tiles (16) and be spaced away from a side of the second tile of that pair of tiles (16); and at least one second engagement portion (25) which is configured to abut against the side of the second tile of the pair of adjacent tiles (16) and be spaced away from the side of the first tile of that pair of tiles (16).
Patent NZ-624082-A (NZ)
Title: Immunocytokine combination therapy
Inventor: SCHWAGER KATHRIN
IPC: C07K16/18
Filed: 2012-06-29
Abstract: Methods and compositions for treating tumours, especially skin tumours, by locally administering single doses of tumour necrosis factor alpha (TNFα) and interleukin-2 (IL2) at the tumour site, where the TNFα and IL2 are delivered as immunoconjugates comprising an antibody targeted to a splice isoform of an extracellular matrix component such as fibronectin.
Patent NZ-625182-A (NZ)
Title: Method for the removal of virus from a protein solution
Inventor: KEPKA CECILIA JANSSON
IPC: C07K1/30
Filed: 2012-12-19
Abstract: Disclosed is a method for selectively removing virus and/or virus DNA from an aqueous solution comprising a target protein, said method comprising: a) adding acetone to the solution at a concentration which selectively precipitates the virus and/or virus DNA, b) performing a separation step to separate precipitated material from the solution comprising the target protein, c) adding to the solution an additional amount of acetone to reach a final concentration which precipitates the target protein, and d) collecting the precipitated target protein from the solution; wherein the concentration of acetone in step a) is 12-40% (v/v).
Patent NZ-625789-A (NZ)
Title: Cableway system for transporting passengers
Inventor: JOHANNES MORITZHUBER
IPC: B61B7/00
Filed: 2014-06-03
Abstract: Disclosed is a gondola cableway system for transporting passengers where at a station a tunnel screen or lobby, the same environmental conditions are maintained between the cars and the station interior and minimises effects of adverse outside weather conditions on passengers. The cableway system includes at least one vehicle to be coupled to a conveying cable or a traction cable for moving the vehicle along a traveling route between stations with the vehicle being coupled to the conveying cable or the traction cable. The vehicle is decoupled from the conveying cable or the traction cable while being moved through a station along a movement path, and the vehicle is once more coupled to the conveying cable or the traction cable for moving out of and away from the station. Thea station building is formed with an entry or exit region for the passengers where the vehicle on moving through the station is moved past, or briefly stopped, at an embarkation or disembarkation point adjoining the entry or exit region for the passengers. The vehicle is boarded or vacated by the passengers. The station building has a screen disposed between the movement path of the vehicle and the entry or exit region for the passengers, the screen having at least one passage opening formed therein for the passengers at the embarkation or disembarkation point. The screen is a wall. The screen has first and second passage openings formed therein, the first passage opening being provided for the passengers boarding a vehicle and the second passage opening being provided for the passengers alighting from the vehicle. First and second doors are disposed to selectively close the first and second passage openings, respectively. The doors are controlled to assume an open or closed position in dependence on a position of the vehicle.
Patent NZ-700309-A (NZ)
Title: Device of a floating gangway, and uses thereof
Inventor: ASBJØRN NES
IPC: E01D15/24
Filed: 2013-03-16
Abstract: A device for a construction of a floating gangway comprising a number of gangway sections (20,30,40) that are supported by a number of pontoons (A,B..), and a number of the respective end sections of the two adjoining gangway sections (20,30) are mounted so that they can swing approximately horizontally to a common supporting pontoon via correspondingly shaped male and female coupling bodies (22,60;24,62), wherein the coupling bodies (60,62) associated with said two adjoining gangway sections (20,30;30,40) are connected to a locking body that restricts their mutual swing movement to between a position where the gangway sections (20,30;30,40) are approximately in parallel and a position where they form an angle a that is less than 180°, and the construction comprises means to synchronize the mutual swing movement of the sections so that when the one section is rotated about its mounting (22) in the pontoon, the second section is rotated the opposite way about its mounting (24) in the pontoon.
Patent NZ-702835-A (NZ)
Title: 3-o-heteroaryl-ingenol
Inventor: Högberg Thomas
IPC: C07D239/34
Filed: 2013-06-21
Abstract: The present invention relates to a compound according to formula (I) wherein R1 represents optionally substituted heteroaryl, and pharmaceutically acceptable salts, hydrates, solvates or pharmaceutically acceptable and physiologically cleavable esters thereof. The invention relates further to intermediates for the preparation of said compounds, to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. diseases associated with hyperplasia, neoplasia or dysplasia, with said compounds, to methods of treatment of cosmetic indications with said compounds, and to the use of said compounds in the manufacture of medicaments.
Patent NZ-717800-A (NZ)
Title: Transportable body
Inventor: MACLEAN BENJAMIN JOHN
IPC: B62D33/00
Filed: 2014-09-11
Abstract: The present invention relates to a mobile transportable body of an improved construction that does not require mechanical fasteners. The mobile or transportable body has a floor (12) and opposing side walls (14). The floor has opposing side edges having an edge profile defining a plurality of laterally extending projections (36). Each side wall lower edge has a plurality of spaced projection receiving sections (50) and the floor side edge projections (36) are received within the projection receiving sections (50) of the side walls (14). The body further includes a fixture (120) installed adjacent an inner surface of at least one side wall (14). The fixture (120) has at least one wall member (76) having a rear edge and a forward edge, and at least one projection (80) extending from the rear edge. The inner surface of an adjacent side wall (14) has a recess (82) complimentary to the projection (80) and the projection (80) is received and secured within the recess (82).
Patent NZ-725585-A (NZ)
Title: Processes for preparing jak inhibitors and related intermediate compounds
Inventor: WANG HAISHENG
IPC: C07F7/08
Filed: 2010-01-14
Abstract: The present disclosure is related to processes for preparing chiral substituted pyrrolo[2,3-di]pyrimidines as intermediates in synthesis of chiral substituted pyrazolyl pyrrolo[2,3-d]pyrimidines are useful as inhibitors of the Janus Kinases.
Patent NZ-732351-A (NZ)
Title: Compositions with improved urease-inhibiting effect comprising (thio) phosphoric acid triamide and further compounds such as amines and colorants
Inventor: SCHNEIDER KARL-HEINRICH
IPC: C05C9/00
Filed: 2015-12-22
Abstract: A composition comprising: (A) a mixture comprising at least one (thio)phosphoric acid triamide according to the general formula (I) R1R2N-P(X)(NH2)2, wherein X is oxygen or sulfur; R1 is a C1 to C20 alkyl, C3 to C20 cycloalkyl, C6 to C20 aryl, or dialkylaminocarbonyl group; R2 is H, or R1 and R2 together with the nitrogen atom linking them define a 5- or 6-membered satu- rated or unsaturated heterocyclic radical, which optionally comprises 1 or 2 further heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur, and (L1 ) at least one amine selected from the group consisting of (L10), (L11 ), (L12), (L13), (L14), (L15), (L16), (L17), (L18), (L19), (L20), (L21 ), (L22), (L23), (L24), and (L29).
Patent NZ-746797-A (NZ)
Title: Insulated riser clamp
Inventor: DODGE ROBERT
IPC: F16L3/10
Filed: 2017-03-30
Abstract: A riser clamp assembly for receiving and supporting an insulated pipe. The clamp assembly includes a first riser clamp and a second riser clamp. Each of the riser clamps includes a semi-circular body portion extending arcuately between opposite first and second ends and defining an inner cylindrical wall and an outer cylindrical wall extending axial between top and bottom edges. A generally C-shaped metal flange projects radially from the inner cylindrical wall generally midway between the top and bottom edges to define an axial center opening. A support brace extends radially from the outer cylindrical wall adjacent each end of the body portion for interconnecting the first and second riser clamps around the insulated pipe. The C-shaped metal flange and associate body are overmolded with plastic and the C-shaped metal flange includes a plurality of spaced apart axial through-holes for mechanically bonding said plastic with said C-shaped metal flange.
Patent NZ-747310-A (NZ)
Title: Turbine shaft bearing and turbine apparatus
Inventor: KAPLAN URI
IPC: F01K7/34
Filed: 2017-09-13
Abstract: A single turbine module is disclosed. The turbine module comprises: a vaporizer for vaporizing organic motive fluid to be expanded in the turbine module; four axially spaced turbine wheels (see 18A, 18B, 18C, 18D, figure 6), each of which turbine wheels constitutes one expansion stage of said turbine module, the turbine wheels being connected to a common turbine shaft (see 15, figure 6) and being coaxial therewith; an inlet through which organic motive fluid vapor is introduced to a first stage of said turbine wheels; a structured bleeding exit opening (see 67, figure 6) formed in an outer turbine casing of said turbine module; a radial passage (see 63, figure 6) defined between two of said turbine wheels (see 18B, 18C, figure 6) and in fluid communication with said bleeding exit opening, wherein partially expanded organic motive fluid vapor is extracted through said bleeding exit opening and supplied (via 74, figure 7A) to an indirect recuperator (see 81A’, figure 7A) in which heat from said partially expanded organic motive fluid vapor extracted through said bleeding exit opening is indirectly transferred to organic motive fluid condensate to produce indirectly recuperated organic motive fluid condensate to be supplied to a preheater (see 64, figure 7A) for preheating the indirectly recuperated organic motive fluid condensate prior to supplying it to the vaporizer (see 62, figure 7A), such that heat from a heat source fluid supplied to the vaporizer vaporizes the preheated organic motive fluid and heat-depleted heat source fluid exiting the vaporizer is supplied to said preheater so that the indirectly recuperated organic motive fluid condensate is preheated, wherein heat-depleted partially expanded organic motive fluid vapor bleed exiting said indirect recuperator is supplied to a direct contact condenser (see 81A’’, figure 7A) for condensing said heat-depleted partially expanded organic motive fluid vapor bleed with additional organic motive fluid condensate (via 79, figure 7A) from an air or water cooled condenser so that heated organic motive fluid condensate is produced and supplied to a further indirect recuperator (see 84A’, figure 7A) for extracting heat from expanded organic motive fluid vapor exiting a last expansion stage of said turbine module (via 76, figure 7A) to produce said organic motive fluid condensate that is supplied to the indirect recuperator to be heated by the partially expanded organic motive fluid vapor. A significant increase in heat influx is provided to the motive fluid by thermal energy, despite the extraction of heat at an intermediate stage of the turbine and despite the relatively low pressure differential between the interstage-bled motive fluid vapor and the recuperated motive fluid liquid. As a consequence, an increased level of power output can be extracted from the turbine.
Patent NZ-748039-A (NZ)
Title: Anti-jagged anitbodies and methods of use
Inventor: WU YAN
IPC: C07K16/30
Filed: 2013-08-13
Abstract: Disclosed are anti-Jagged antibodies and methods of using the same in the manufacture of a medicament for treating cancer.
Patent NZ-763584-A (NZ)
Title: Hatch section for an electronic aerosol provision device
Inventor: WRIGHT JEREMY
IPC: A24F40/70
Filed: 2018-10-19
Abstract: The present invention relates to a device for an electronic aerosol provision device. The device comprises a housing formed of a chassis section and a hatch section. The hatch section comprises a sleeve for receipt of an aerosol forming component, and a retention section configured to resist removal of the aerosol forming component following insertion into the sleeve. The present invention seeks to provide a device which can retain, and resist inadvertent removal of, an aerosol forming component received therein.
Patent NZ-764680-A (NZ)
Title: Spray-dried 3-fucosyllactose
Inventor: JENNEWEIN STEFAN
IPC: A23P10/40
Filed: 2018-12-07
Abstract: Disclosed is a method for the manufacture of a spray-dried powder consisting essentially of 3-fucosyllactose (3-FL), the spray-dried powder, its use for the manufacture of nutritional compositions, and nutritional compositions containing the spray-dried powder. In particular, the present invention relates to a nutritional composition comprising a spray-dried powder comprising 80%-wt. 3-FL which has been produced by microbial fermentation. The spray-dried powder contains less than 15%-wt. of water and is free of genetically-modified microbes and nucleic acids derived from these microbes. The nutritional composition further comprises a probiotic microorganism.
Patent NZ-777613-A (NZ)
Title: Printed coverslip and slide for identifying reference focal plane for light microscopy
Inventor: CAHOON BENJAMIN
IPC: G02B21/34
Filed: 2020-01-17
Abstract: A method comprising; scanning a coverslip or a slide with an optical microscope to generate an overview image; identifying a fiducial marker printed on a surface of a coverslip or a surface of a slide based on the overview image; calculating a focal distance to the fiducial marker when focusing the optical microscope on the fiducial marker; and calculating a reference focal plane defining the surface of the coverslip or the surface of the slide based on the focal distance of the fiducial marker.
Patent NZ-780730-A (NZ)
Title: Method and apparatus for intra-prediction
Inventor: ESENLIK SEMIH
IPC: H04N19/11
Filed: 2020-03-23
Abstract: Devices and methods for intra prediction of DC intra prediction mode are provided. The method includes: obtaining a value of an intra prediction reference line index of a transform block; obtaining prediction samples of the transform block based on reference samples from a reference line, wherein the reference line is indexed by the value of the intra prediction reference line index refIdx, the value of refIdx being non-zero. Wherein the prediction samples of the transform block predSamples[x][y] are obtained by: predSamples[ x ][ y ] = dcVal, with x = 0.. nTbW − 1, y = 0..nTbH – 1, when nTbW is greater than nTbH, only reference samples from a top reference line are used to obtain the prediction samples, when nTbH is greater than nTbW, only reference samples from a left reference line are used to obtain the prediction samples. The method introduces a harmonization of MRL and non-directional intra prediction (i.e. DC). The harmonization consists in aligning the reference samples from a reference line, which is indexed by the value of the intra prediction reference line index.
Patent NZ-790013-A (NZ)
Title: Method of treatment of infection
Inventor: ALAWI FADIL AL
IPC: A61K31/365
Filed: 2011-01-20
Abstract: The disclosure relates to an injectable composition for the treatment of a microbial infection in a mammary gland of a non-human animal, wherein the composition includes: (a) a non-steroidal anti-inflammatory drug (NSAID); (b) an antibiotic selected from the group consisting of a beta lactam antibiotic and macrolide antibiotic; (c) a solubilising agent selected from the group consisting of dimethyl sulfoxide (DMSO), dimethylacetamide (DMA) glycerine formal, and benzyl alcohol; and (d) propylene glycol as a carrier, wherein the amount of propylene glycol in the composition is more than the amount of solubilising agent in the composition; and wherein the NSAID and antibiotic are dissolved in the solubilising agent and propylene glycol.